Skip to content
Join our Newsletter

Your Good Health: Man plagued by hot flashes and night sweats

Dear Dr. Roach: My husband successfully completed 45 days of radiation for prostate cancer. His last PSA was non-detectable. He has to take medication for two years as part of the cure.
dr_keith_roach_with_bkg.jpg
Dr. Keith Roach writes a medical question-and-answer column weekdays.

dr_keith_roach_with_bkg.jpgDear Dr. Roach: My husband successfully completed 45 days of radiation for prostate cancer. His last PSA was non-detectable. He has to take medication for two years as part of the cure. However, it is causing him to have horrible hot flashes and night sweats. The usual over-the-counter solutions for women do not seem to be helping at all. Would you suggest something designed for a male?

P.B.

The first effective treatment for prostate cancer was depriving the cancer cells of androgens, which was initially done surgically, by removing the testes. It is done now with medications that act similar to gonadotropin-releasing hormone. Although these initially stimulate testosterone production, their continued use causes lower levels of testosterone, and within a month testosterone levels drop to the same levels as in men who have had surgery to remove their testes.

Hot flashes occur in 80% of men and can be very disruptive. Treatments that are effective for women are often not effective in men, as you observed.

The best-studied and most effective treatments in men were medroxyprogesterone (a hormone that opposes some actions of estrogen) and cyproterone (an antiandrogen available in Canada, but not the U.S.). It reduced hot flashes by 84% to 95% in men. Venlafaxine, normally used as an antidepressant, reduced symptoms by 50%, and gabapentin, used for epilepsy or for nerve pain, reduced symptoms by about 45%.

It’s very important to treat the symptoms so he can continue this treatment, which is part of his best chance for long-term remission from prostate cancer.

Dr. Roach regrets that he is unable to answer individual letters, but will incorporate them in the column whenever possible. Readers can email questions to [email protected].